You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
McKinsey
Johnson and Johnson
Dow
McKesson

Last Updated: August 6, 2020

DrugPatentWatch Database Preview

EMADINE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Emadine, and what generic alternatives are available?

Emadine is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in EMADINE is emedastine difumarate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the emedastine difumarate profile page.

US Patents and Regulatory Information for EMADINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis EMADINE emedastine difumarate SOLUTION/DROPS;OPHTHALMIC 020706-001 Dec 29, 1997 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for EMADINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis EMADINE emedastine difumarate SOLUTION/DROPS;OPHTHALMIC 020706-001 Dec 29, 1997   Start Trial   Start Trial
Novartis EMADINE emedastine difumarate SOLUTION/DROPS;OPHTHALMIC 020706-001 Dec 29, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Boehringer Ingelheim
Dow
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.